Vical Reports Positive Swine Flu Vaccine Results

Vical Inc. (Nasdaq: VICL) reported positive results that its swine flu vaccine works in mice. Shares of the biopharmaceutical leaped 50 cents to close at $2.70.

About this Entry

This page contains a single entry by published on June 30, 2009 1:54 PM.

Novavax To Development Genetically Engineered Vaccines was the previous entry in this blog.

EXCO To Sell 50% Stake Of Haynesville Shale is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12